# Accelerated HEmodiafiltration in Severe Acute Diquat (AHEAD) Poisoning

> **NCT07234383** · PHASE1 · NOT_YET_RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 24 (estimated)

## Conditions studied

- Diquat Poisoning

## Interventions

- **PROCEDURE:** Continuous Veno-Venous Hemodiafiltration

## Key facts

- **NCT ID:** NCT07234383
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07234383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07234383, "Accelerated HEmodiafiltration in Severe Acute Diquat (AHEAD) Poisoning". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07234383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
